Q1 FY'22 Financial Overview
Investing in Future Organic Growth
Research & Development
($ and in % of Total Revenues) (1),(2)
Sales & Marketing
R&D %
of Total Revenues
R&D US$
10.5%
12-14%
12.2%
$194 M
$412 M
FY'15
FY'21
FY'22
$2.2B+ investment in R&D over the next 5 years
Enterprise Sales Goal
• Full coverage of G10K by end of CY'23
SMB/C Goal
Grow SMB/C partners - RMMS, MSPs
Customer Engagement
Increased investment in Digital Zone
opentext™
1. Please refer to "Use of Non-GAAP Financial Measures" at the end of this presentation and "Reconciliation of selected GAAP-based measures to Non-GAAP-based measures" included within our current
and historical filings on Forms 10-Q, 10-K and 8-K.
OpenText ©2021 All rights reserved
28
2. Refers to non-GAAP R&D expense. Refer to note 1 of our Fiscal 2019 10-K for details on the impact of recently adopted accounting standards on prior period results.View entire presentation